V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260012508 | 260013565 | 1.63 | 106 | Curative (C) | 2016-10-08 | 2016-10-10 | BEP 5 Day | 02 | N | 260023817 | BEP |
| 260012509 | 260013565 | 1.69 | 74.55 | Curative (C) | 2017-11-08 | 2018-02-09 | BENDAMUSTINE + RITUXIMAB | N | N | 260023817 | BENDAMUSTINE + RITUXIMAB |
| 260012510 | 260013565 | 1.85 | 60 | Curative (C) | 2017-04-25 | 2017-05-05 | BEP 3 day | 02 | N | 260023817 | BEP |
| 260012511 | 260007801 | 1.63 | 74.5 | Curative (C) | 2016-01-28 | 2016-01-29 | BEP 5 Day | null | N | 260023825 | BEP |
| 260012512 | 260017865 | 1.77 | 58.1 | Curative (C) | 2016-03-18 | 2016-04-23 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023828 | BENDAMUSTINE + RITUXIMAB |
| 260012513 | 260007803 | 1.65 | null | Curative (C) | 2013-07-27 | 2013-11-17 | Bendamustine+Rituximab(Sub Courses) | N | N | 260023833 | BENDAMUSTINE + RITUXIMAB |
| 260012514 | 260007803 | 1.85 | 64.6 | Adjuvant (A) | null | 2018-04-28 | BEP 5 Day | N | N | 260023833 | BEP |
| 260012515 | 260007804 | null | null | Disease modification (D) | 2016-06-05 | 2016-06-26 | BEP 3 day | null | null | 260023836 | BEP |
| 260012516 | 260013569 | 1.69 | 76 | Curative (C) | 2017-07-10 | 2017-07-11 | BEP 3 day | N | N | 260023838 | BEP |
| 260012517 | 260013569 | 1.64 | 90.7 | Not known (9) | null | 2015-03-29 | BEP 5 Day | null | null | 260023838 | BEP |
| 260012518 | 260013569 | 1.76 | 81.9 | Adjuvant (A) | 2014-06-02 | 2014-06-10 | BEP 3 day | null | null | 260023838 | BEP |
| 260012519 | 260013569 | 1.7 | 55 | null | 2017-12-10 | 2017-12-19 | BEP 5 Day | 02 | N | 260023838 | BEP |
| 260012520 | 260007805 | 1.65 | 90 | Curative (C) | 2015-09-29 | 2015-10-05 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260023842 | BENDAMUSTINE + RITUXIMAB |
| 260012521 | 260007805 | 1.75 | 86.9 | Curative (C) | 2013-08-11 | 2013-08-17 | BEP 3 day | null | null | 260023842 | BEP |
| 260012522 | 260007808 | 1.77 | 73.1 | Curative (C) | 2017-10-17 | 2017-10-27 | Bendamustine+Rituximab (1st Course) | 2 | N | 260023852 | BENDAMUSTINE + RITUXIMAB |
| 260012523 | 260007808 | 1.95 | 76 | Curative (C) | 2013-07-12 | 2013-09-22 | Bendamustine+Rituximab(Sub Courses) | N | N | 260023852 | BENDAMUSTINE + RITUXIMAB |
| 260012524 | 260007808 | null | 62.8 | Curative (C) | null | 2014-08-21 | BENDAMUSTINE + RITUXIMAB | null | N | 260023852 | BENDAMUSTINE + RITUXIMAB |
| 260012525 | 260007809 | 1.57 | 78 | Curative (C) | 2013-07-15 | 2013-07-16 | BEP 3 day | N | N | 260023868 | BEP |
| 260012526 | 260007810 | 1.68 | 77.9 | Curative (C) | 2014-06-06 | 2014-06-06 | BEP 3 day | 02 | N | 260023869 | BEP |
| 260012527 | 260007811 | null | null | Curative (C) | 2013-09-20 | 2013-10-04 | BEP 3 day | N | N | 260023873 | BEP |
| 260012528 | 260013573 | 1.85 | null | Curative (C) | 2017-02-05 | 2017-02-11 | BEP 5 Day | null | N | 260023874 | BEP |
| 260012529 | 260013573 | 1.63 | 89.1 | null | 2018-08-30 | 2018-08-30 | BEP 3 day | 02 | null | 260023874 | BEP |
| 260012530 | 260007813 | null | 87.7 | Curative (C) | 2015-01-05 | 2015-02-02 | BEP 3 day | 02 | N | 260023876 | BEP |
| 260012531 | 260007813 | 1.87 | 42.5 | Curative (C) | 2015-09-21 | 2015-11-03 | Bendamustine+Rituximab(Sub Courses) | N | null | 260023876 | BENDAMUSTINE + RITUXIMAB |
| 260012532 | 260007815 | 1.65 | 94 | Palliative (P) | 2014-08-24 | 2014-10-02 | BEP 5 Day | N | N | 260023880 | BEP |
| 260012533 | 260013575 | 1.84 | 60.4 | Disease modification (D) | 2016-01-31 | 2016-03-06 | BENDAMUSTINE + RITUXIMAB | null | N | 260023880 | BENDAMUSTINE + RITUXIMAB |
| 260012534 | 260007817 | 1.6 | 95.3 | Palliative (P) | 2016-02-04 | 2016-02-04 | BEP 5 Day | 02 | N | 260023884 | BEP |
| 260012535 | 260013576 | null | null | null | 2017-09-19 | 2017-10-26 | BEP 3 day | N | N | 260023884 | BEP |
| 260012536 | 260013576 | 1.8 | 70 | Adjuvant (A) | 2016-02-14 | 2016-03-28 | BENDAMUSTINE + RITUXIMAB | N | N | 260023884 | BENDAMUSTINE + RITUXIMAB |
| 260012537 | 260013576 | 1.72 | null | Curative (C) | 2015-12-02 | 2015-12-02 | BEP 5 Day | N | N | 260023884 | BEP |
| 260012538 | 260007819 | 1.6 | 77 | Curative (C) | 2014-02-21 | 2014-03-05 | BEP 3 day | N | null | 260023897 | BEP |
| 260012539 | 260007819 | 1.68 | 90 | Curative (C) | 2017-12-14 | 2018-01-18 | BEP 3 day | N | N | 260023897 | BEP |
| 260012540 | 260007821 | 1.54 | 65.9 | Disease modification (D) | null | 2013-10-17 | Bendamustine+Rituximab(Sub Courses) | N | N | 260023900 | BENDAMUSTINE + RITUXIMAB |
| 260012541 | 260007821 | null | null | Disease modification (D) | 2013-04-06 | 2013-04-21 | Bendamustine+Rituximab(Sub Courses) | null | null | 260023900 | BENDAMUSTINE + RITUXIMAB |
| 260012542 | 260018603 | 1.58 | 69.5 | Not known (9) | 2018-04-16 | 2018-05-07 | BENDAMUSTINE + RITUXIMAB | N | N | 260023905 | BENDAMUSTINE + RITUXIMAB |
| 260012543 | 260018603 | 1.64 | 62 | Curative (C) | 2016-08-28 | 2016-09-11 | BEP 5 Day | N | N | 260023905 | BEP |
| 260012544 | 260016427 | 1.46 | 60.8 | Disease modification (D) | 2014-07-15 | 2014-07-20 | Bendamustine+Rituximab (1st Course) | N | null | 260023909 | BENDAMUSTINE + RITUXIMAB |
| 260012545 | 260018604 | 1.81 | 108.8 | Not known (9) | 2015-03-10 | 2015-03-10 | BEP 3 day | 2 | N | 260023911 | BEP |
| 260012546 | 260007823 | 1.8 | 76 | Curative (C) | 2013-04-20 | 2013-04-22 | BEP 5 Day | N | N | 260023911 | BEP |
| 260012547 | 260007824 | null | 118 | Adjuvant (A) | 2016-03-28 | 2016-03-28 | BEP 3 day | null | N | 260023916 | BEP |
| 260012548 | 260007824 | 1.79 | 76.7 | Curative (C) | 2016-05-15 | 2016-05-22 | BEP 3 day | Y | N | 260023916 | BEP |
| 260012549 | 260007825 | 1.87 | 63.95 | Adjuvant (A) | 2015-08-25 | 2015-09-11 | BEP 3 day | N | N | 260023919 | BEP |
| 260012550 | 260016428 | 1.76 | 91.8 | Curative (C) | 2017-03-12 | 2017-03-12 | BEP 5 Day | 02 | N | 260023920 | BEP |
| 260012551 | 260007826 | 1.8 | 84 | Curative (C) | 2013-05-24 | 2013-06-07 | Bendamustine+Rituximab(Sub Courses) | N | N | 260023920 | BENDAMUSTINE + RITUXIMAB |
| 260012552 | 260007826 | 1.73 | 72 | null | 2013-07-30 | 2013-08-05 | BENDAMUSTINE + RITUXIMAB | N | N | 260023920 | BENDAMUSTINE + RITUXIMAB |
| 260012553 | 260007826 | 0 | 62.2 | Curative (C) | 2018-01-18 | 2018-01-18 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023920 | BENDAMUSTINE + RITUXIMAB |
| 260012554 | 260007826 | null | null | Adjuvant (A) | null | 2017-12-25 | Bendamustine+Rituximab(Sub Courses) | null | N | 260023920 | BENDAMUSTINE + RITUXIMAB |
| 260012555 | 260007827 | 1.76 | null | Curative (C) | 2012-12-12 | 2013-03-07 | BENDAMUSTINE + RITUXIMAB | N | null | 260023942 | BENDAMUSTINE + RITUXIMAB |
| 260012556 | 260013584 | 1.75 | 93.9 | Curative (C) | 2017-09-05 | 2017-10-12 | BEP 3 day | N | N | 260023948 | BEP |
| 260012557 | 260007828 | null | 52.9 | null | 2014-10-28 | 2014-11-12 | BEP 5 Day | 02 | null | 260023948 | BEP |